Shionogi & Co., Ltd. (ADR)
General ticker "SGIOY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $7.7B (TTM average)
Shionogi & Co., Ltd. (ADR) follows the US Stock Market performance with the rate: 28.3%.
Estimated limits based on current volatility of 1.3%: low 8.77$, high 9.00$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2026-03-31, amount 0.10$ (Y2.29%)
- Price in estimated range
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [6.71$, 9.89$]
- 2026-03-31 to 2027-03-31 estimated range: [7.10$, 10.43$]
Financial Metrics affecting the SGIOY estimates:
- Positive: with PPE of 14.7 at the end of fiscal year the price was low
- Positive: Operating profit margin, % of 36.46 > 18.39
- Positive: 6.59 < Operating cash flow per share per price, % of 10.03
- Negative: 0.01 < Interest expense per share per price, % of 0.46
- Negative: negative Industry operating income (median)
- Negative: Shareholder equity ratio, % of 88.70 > 64.29
- Positive: -14.17 < Investing cash flow per share per price, % of -6.63
Short-term SGIOY quotes
Long-term SGIOY plot with estimates
Financial data
| YTD | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|
| Operating Revenue | ¥435,081.00MM | ¥438,268.00MM | ¥529,811.44MM |
| Operating Expenses | ¥263,621.00MM | ¥278,489.00MM | ¥358,698.96MM |
| Operating Income | ¥171,460.00MM | ¥159,779.00MM | ¥171,112.48MM |
| Non-Operating Income | ¥26,823.00MM | ¥40,971.00MM | ¥82,212.03MM |
| Interest Expense | ¥6,701.00MM | ¥9,027.00MM | ¥9,123.95MM |
| R&D Expense | ¥102,640.00MM | ¥108,612.00MM | ¥130,251.40MM |
| Income(Loss) | ¥198,283.00MM | ¥200,750.00MM | ¥253,324.51MM |
| Taxes | ¥37,708.00MM | ¥31,215.00MM | ¥34,992.28MM |
| Net Income(Loss)* | ¥162,030.00MM | ¥170,434.00MM | ¥217,532.76MM |
| Stockholders Equity | ¥1,235,326.00MM | ¥1,361,924.00MM | ¥1,692,524.06MM |
| Inventory | ¥64,916.00MM | ¥65,477.00MM | ¥99,827.10MM |
| Assets | ¥1,416,918.00MM | ¥1,535,349.00MM | ¥2,588,046.32MM |
| Operating Cash Flow | ¥154,284.00MM | ¥195,460.00MM | ¥226,452.07MM |
| Capital expenditure | ¥28,267.00MM | ¥17,126.00MM | ¥15,336.29MM |
| Investing Cash Flow | ¥5,922.00MM | ¥-129,069.00MM | ¥-536,661.03MM |
| Financing Cash Flow | ¥-126,853.00MM | ¥-51,919.00MM | ¥635,464.76MM |
| Earnings Per Share** | ¥93.08 | ¥100.18 | ¥127.82 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.